Bulletin
Investor Alert

London Markets Open in:

Market Pulse Archives

Dec. 18, 2020, 8:17 a.m. EST

E.U. to buy an additional 80 million doses of Moderna's coronavirus vaccine

new
Watchlist Relevance
LEARN MORE

Want to see how this story relates to your watchlist?

Just add items to create a watchlist now:

  • X
    Moderna Inc. (MRNA)
  • X
    S&P 500 Index (SPX)

or Cancel Already have a watchlist? Log In

By Jaimy Lee

Shares of Moderna Inc. /zigman2/quotes/205619834/composite MRNA +11.80% were down 0.1% in premarket trading on Friday after the company said the European Commission now plans to purchase an additional 80 million doses of its COVID-19 vaccine candidate. The commission had previously made a deal for 80 million doses. Moderna's still investigational vaccine requires two doses for each person, spaced one month apart. It has not yet been approved or authorized in any country; however, an emergency use authorization from the Food and Drug Administration is expected at any time. European Union health officials are expected to decide whether to grant a conditional marketing authorization for the vaccine on Jan. 6. Moderna's stock has soared 636.2% so far this year, while the S&P 500 /zigman2/quotes/210599714/realtime SPX +1.32% is up 15.2%.

/zigman2/quotes/205619834/composite
US : U.S.: Nasdaq
$ 368.51
+38.88 +11.80%
Volume: 33.95M
Nov. 29, 2021 4:00p
P/E Ratio
22.63
Dividend Yield
N/A
Market Cap
$133.65 billion
Rev. per Employee
$617,996
loading...
/zigman2/quotes/210599714/realtime
US : S&P US
4,655.27
+60.65 +1.32%
Volume: 2.50B
Nov. 29, 2021 4:57p
loading...

This Story has 0 Comments
Be the first to comment
More News In
Industries

Story Conversation

Commenting FAQs »

Partner Center

Link to MarketWatch's Slice.